S*Bio and A*Star to develop new compounds to treat cancer(02/08/2007) S*BIO Pte Ltd, a privately held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer, announced that it has signed a two-year Master Research Collaboration Agreement with ...
Singapore scientists develop new synthetic protein that targets and kills cancer cells(12/08/2004) Scientists from A*STAR's Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) have developed a new synthetic protein fragment which can target and kill cancer cells. The team is now working on an improved version that ...